JO3550B1 - مركب لمعالجة سرطان البروستاتا - Google Patents

مركب لمعالجة سرطان البروستاتا

Info

Publication number
JO3550B1
JO3550B1 JOP/2010/0128A JOP20100128A JO3550B1 JO 3550 B1 JO3550 B1 JO 3550B1 JO P20100128 A JOP20100128 A JO P20100128A JO 3550 B1 JO3550 B1 JO 3550B1
Authority
JO
Jordan
Prior art keywords
treatment
composition
prostate cancer
prostate
cancer
Prior art date
Application number
JOP/2010/0128A
Other languages
English (en)
Inventor
Cantor Per
Erichsen Lars
Kold Olesen Tine
Original Assignee
Ferring Int Center Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Int Center Sa filed Critical Ferring Int Center Sa
Application granted granted Critical
Publication of JO3550B1 publication Critical patent/JO3550B1/ar

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

يتعلق الاختراع الحالي بتوفير تركيبة لعلاج سرطان البروستاتا
JOP/2010/0128A 2009-05-01 2010-04-25 مركب لمعالجة سرطان البروستاتا JO3550B1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09251242 2009-05-01
US18781909P 2009-06-17 2009-06-17

Publications (1)

Publication Number Publication Date
JO3550B1 true JO3550B1 (ar) 2020-07-05

Family

ID=65524059

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2010/0128A JO3550B1 (ar) 2009-05-01 2010-04-25 مركب لمعالجة سرطان البروستاتا

Country Status (2)

Country Link
JP (1) JP7085958B2 (ar)
JO (1) JO3550B1 (ar)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117057D0 (en) 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition

Also Published As

Publication number Publication date
JP7085958B2 (ja) 2022-06-17
JP2019031534A (ja) 2019-02-28

Similar Documents

Publication Publication Date Title
MX2011011431A (es) Composicion para el tratamiento de cancer de prostata.
MY160390A (en) Vinyl indazolyl compounds
PL2482849T3 (pl) Skojarzona immunoterapia w leczeniu nowotworu
EP2461814A4 (en) PROSTATE CANCER TREATMENT
ZA201106586B (en) Amatoxin-armed target-binding moieties for the treatment of cancer
IL218575A0 (en) Treatment of cancer
PT2303021T (pt) Compostos para tratamento do cancro
MX2011006290A (es) Compuestos de aza-azuleno.
IN2011KN03851A (ar)
MX2009008132A (es) Terapia de combinacion con inhibidores de angiogenesis.
MX2014005458A (es) Inhibidor doble de met y del factor de crecimiento endotelial vascular (vegf) para el tratamiento del cáncer.
SG173672A1 (en) Novel ortho-aminoamides for the treatment of cancer
IL214746A0 (en) Substituted pyrimidines for the treatment of cancer
EP2424516A4 (en) PENTAMIDINE COMBINATIONS FOR THE TREATMENT OF CANCER
PL2605764T3 (pl) Kompozycje do leczenia nowotworu
ZA201300762B (en) Novel combination therapy for the treatment of cancer
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
PT3388111T (pt) Composto organoarsénico para o tratamento de cancro
GB0916686D0 (en) Treatment of cancer
JO3550B1 (ar) مركب لمعالجة سرطان البروستاتا
AP2011005893A0 (en) Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer.
WO2012037553A9 (en) Use of pkc-iota inhibitors for the treatment of breast cancer
TN2011000013A1 (en) Amidophenoxyindazoles useful as inhibitors of c-met
HK1185283A (zh) 用於前列腺癌治疗的联合治疗
AU2009900764A0 (en) Treatment of cancer